Curation of an international drug proprietary names dataset
No Thumbnail Available
Date
2021-11-22
Authors
Mohammad A. Khaleel
Amer Hayat Khan
S.M. Sheikh Ghadzi
Sami Alshakhshir
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
A drug dataset containing international proprietary names is essential for researchers investigating different drugs from different countries worldwide. However, many websites on the internet offer free access for a single drug searching service to identify international drug trade names, but not for a list of drugs to be searched and identified. Therefore, it will be problematic if the researcher has a list of hundreds or thousands of drug trade names to be identified. In this project, we have created an International Drug Dictionary (IDD) by curating collected drug lists from open access websites belonging to official drug regulatory agencies, official healthcare systems, or recognized scientific bodies from 44 countries around the world in addition to the European public assessment reports (EPAR) and the DRUGBANK vocabulary published in the public domain. Researchers interested in pharmacovigilance, pharmacoepidemiology, or pharmacoeconomics can benefit from this dataset, especially when identifying lists of proprietary drug names, particularly of multi-national origin.
To enhance its adaptability, we also mapped the IDD to the standardized drug vocabulary RxNorm. The IDD can also be used as a tool for mapping international drug trade names to RxNorm. Each drug entity in the IDD mapped to a unique identification number for each entity called Atom Unique Identifier (RXAUI) from RxNorm.
Description
We downloaded the datasets from the official websites of drug authorities or agencies in 44 countries in addition to the European public assessment reports (EPAR) and the DRUGBANK vocabulary.
Link to data: https://data.mendeley.com/datasets/9nmgzttxhm/1